MedTrace Logo

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

NCT01616069 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2015-06-02

No results posted yet for this study

Summary

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

Conditions

  • Cardiopulmonary Bypass Graft

Interventions

DRUG

epinephrine and levosimendan

epinephrine (0,06mcg/kg/min), levosimendan (0,2 mcg/kg/min)

Sponsors & Collaborators

  • Universidade Federal do Rio de Janeiro

    collaborator OTHER

  • National Institute of Cardiology/Ministry of Health

    collaborator UNKNOWN

  • Federal University of Juiz de Fora

    lead OTHER

Principal Investigators

  • Marcello F Salgado Filho, Master · National Institute of Cardiology/Ministry of Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-02-29
Completion
2013-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01616069 on ClinicalTrials.gov